| abstract |
The present invention relates to methylene urea derivatives of formulas (I) and (II), the use of the compounds of formulas (I) and (II) as inhibitors of raf-kinase, the use of the compounds of formulas (I) and (II) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient. The formulas (I) and (II) are: A-D-B (I) (see formula II). |